S. Said (Stony Brook, United States Of America), T. R. Martin (Seattle, United States of America)
Analysis of exhaled breath condensate proteom and BAL Proteom by matrix assisted laser desorption/ioniosation – time of flight (MALDI-TOF) from patients with acute lung injury C. Gessner, H. Dihazi, J. Frenzel, S. Brettschneider, S. Hammerschmidt, H. Kuhn, J. Schauer, H. Wirtz (Leipzig, Germany)
| |
Upregulated HIF (hypoxia inducible factor)-1 DNA binding activity to VEGF-a promoter mediates oedema formation in donor lung grafts S. Aharinejad, K. Krenn, P. Paulus, W. Klepetko, D. Abraham (Vienna, Austria)
| |
TGFβ1 induced loss of β-adrenergic response in human bronchial smooth muscle cells (hBSMC) is dependent on TGFβ-RI kinase activity: potential therapeutic application in treating airway diseases Y. Feng, A. Nguyen, A. Lam, A. Kapoun, G. Schreiner, L. S. Higgins (Sunnyvale, United States Of America)
| |
Clara cell specific protein (CC16) after LPS inhalation in healthy subjects O. Michel, A. Bernard (Brussels, Belgium)
| |
Insulin-like growth factor binding protein-3 induction by transforming growth factor-β1 mediates differentiation of a myofibroblast phenotype in human lung fibroblasts J. T. Allen, E. Parker, R. A. Knight, M. A. Spiteri (Stoke-on-Trent, London, United Kingdom)
| |
Thrombin activates mitogen activated protein (MAP) kinase and activated protein-1 (AP-1) to induce interleukin-8 (IL-8) release from airway epithelial cells H. C. Lin, C. T. Yu, C. H. Wang, C. K. Yang, C. T. Huang, J. T. Huang, H. P. Kuo (Taipei, Taiwan)
| |
Proteinase-activated receptor-2 (PAR2) activation on human lung fibroblasts increases IL-6 & IL-8 mRNA expression R. Ramachandran, A. H. Morice, S. J. Compton (Hull, United Kingdom)
| |
Inhibition of HGF secretion by pulmonary fibroblasts from IPF: involvement of PGE2 S. Marchand-Adam, J. Marchal, M. Cohen, P. Soler, M. Dehoux, G. Leseche, M. Fournier, M. Aubier, B. Crestani (Paris, Clichy, France)
| |